The Institute for Surgical Excellence (ISE) has appointed Dr. Ahmed Ghazi to its Board of Directors. ISE is a 501(c)(3) non-profit organization that convenes leading innovators, surgeons, surgical societies, hospital executives, and government to develop consistent, teachable, and measurable surgical standards that directly improve patient outcomes.
Dr. Ghazi is a urologist and robotic surgeon who specializes in the diagnosis and minimally invasive treatment of prostate, bladder, kidney, and testicular cancers. He received his MD degree from Cairo University in Egypt in 2000, where he completed his surgical training and Urology residency. He completed a laparoscopic fellowship in Paris, France in 2008 under the supervision of Professor Claude Abbou, MD, and is accredited by the European Board of Urology. He completed a second laparoscopic fellowship in Austria in 2009 under the supervision of Professor Gunter Janetschek, MD who specialized in the laparoscopic approach for selective removal of kidney tumors, preserving the kidney. He then completed his training at the University of Rochester with a two-year fellowship in the robotic treatment of various urologic cancers. He joined the staff at the Urology Department, University of Rochester in 2012. Dr. Ghazi is in on the cutting edge of research in AI and surgical metrics as well as creating the next generation of surgical training models.
Robotic surgery is transforming the healthcare landscape. With minimally invasive techniques and precision, surgeons can challenge traditional operating procedures by reducing pain, risk, and recovery time. Today, robotic surgeries are primarily used in gynecology, urology, thoracic surgery, general surgery, and colorectal surgery.
“The institute for surgical excellence has been such an important global leader, raising standards of care. I am proud to be able to contribute to the success of ISE and its necessary work,” said Dr. Ahmed Ghazi
“Dr. Ghazi’s experience with advanced robotic surgery, innovations in training, and cutting edge research will enhance ISE’s vision of next-generation patient care and surgical excellence to improve patient outcomes,” said Dr. Jeffrey Levy, ISE’s Interim Executive Director.
Provided information and photo
